The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males. Issue 7 (3rd July 2022)
- Record Type:
- Journal Article
- Title:
- The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males. Issue 7 (3rd July 2022)
- Main Title:
- The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males
- Authors:
- Croci, Susanna
Venneri, Mary Anna
Mantovani, Stefania
Fallerini, Chiara
Benetti, Elisa
Picchiotti, Nicola
Campolo, Federica
Imperatore, Francesco
Palmieri, Maria
Daga, Sergio
Gabbi, Chiara
Montagnani, Francesca
Beligni, Giada
Farias, Ticiana D.J.
Carriero, Miriam Lucia
Di Sarno, Laura
Alaverdian, Diana
Aslaksen, Sigrid
Cubellis, Maria Vittoria
Spiga, Ottavia
Baldassarri, Margherita
Fava, Francesca
Norman, Paul J.
Frullanti, Elisa
Isidori, Andrea M.
Amoroso, Antonio
Mari, Francesca
Furini, Simone
Mondelli, Mario U
GEN-COVID multicenter study,
Chiariello, Mario
Renieri, Alessandra
Meloni, Ilaria
… (more) - Abstract:
- ABSTRACT: The polymorphism L412F in TLR3 has been associated with several infectious diseases. However, the mechanism underlying this association is still unexplored. Here, we show that the L412F polymorphism in TLR3 is a marker of severity in COVID-19. This association increases in the sub-cohort of males. Impaired macroautophagy/autophagy and reduced TNF/TNFα production was demonstrated in HEK293 cells transfected with TLR3 L412F -encoding plasmid and stimulated with specific agonist poly(I:C). A statistically significant reduced survival at 28 days was shown in L412F COVID-19 patients treated with the autophagy-inhibitor hydroxychloroquine (p = 0.038). An increased frequency of autoimmune disorders such as co-morbidity was found in L412F COVID-19 males with specific class II HLA haplotypes prone to autoantigen presentation. Our analyses indicate that L412F polymorphism makes males at risk of severe COVID-19 and provides a rationale for reinterpreting clinical trials considering autophagy pathways. Abbreviations: AP: autophagosome; AUC: area under the curve; BafA1: bafilomycin A1; COVID-19: coronavirus disease-2019; HCQ: hydroxychloroquine; RAP: rapamycin; ROC: receiver operating characteristic; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; TLR: toll like receptor; TNF/TNF-α: tumor necrosis factor
- Is Part Of:
- Autophagy. Volume 18:Issue 7(2022)
- Journal:
- Autophagy
- Issue:
- Volume 18:Issue 7(2022)
- Issue Display:
- Volume 18, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 18
- Issue:
- 7
- Issue Sort Value:
- 2022-0018-0007-0000
- Page Start:
- 1662
- Page End:
- 1672
- Publication Date:
- 2022-07-03
- Subjects:
- Autophagy -- COVID-19 -- HLA -- L412F -- TLR3
Autophagic vacuoles -- Periodicals
Apoptosis -- Periodicals
Cell death -- Periodicals
Lysosomes -- Periodicals
Degeneration (Pathology) -- Periodicals
Autophagy -- Periodicals
Cell Death -- Periodicals
Lysosomes -- Periodicals
Periodicals
571.936 - Journal URLs:
- http://www.tandfonline.com/loi/kaup20#.Vd3NN_lVhBc ↗
http://www.landesbioscience.com/journals/autophagy ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/15548627.2021.1995152 ↗
- Languages:
- English
- ISSNs:
- 1554-8627
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1835.065800
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22562.xml